Walker Donald E, Yang Feng, Carver Joseph, Joe Koman, Michels David A, Yu X Christopher
a Protein Analytical Chemistry , Genentech, A Member of the Roche Group , South San Francisco , CA , USA.
MAbs. 2017 May/Jun;9(4):654-663. doi: 10.1080/19420862.2017.1303023. Epub 2017 Mar 27.
A modular and adaptive mass spectrometry (MS)-based platform was developed to provide fast, robust and sensitive host cell protein (HCP) analytics to support process development. This platform relies on one-dimensional ultra-high performance liquid chromatography (1D UHPLC) combined with several different MS data acquisition strategies to meet the needs of purification process development. The workflow was designed to allow HCP composition and quantitation for up to 20 samples per day, a throughput considered essential for real time bioprocess development support. With data-dependent acquisition (DDA), the 1D UHPLC-MS/MS method had excellent speed and demonstrated robustness in detecting unknown HCPs at ≥ 50 ng/mg (ppm) level. Combining 1D UHPLC with sequential window acquisition of all theoretical spectra (SWATH) MS enabled simultaneous detection and quantitation of all HCPs in single-digit ng/mg range within 1 hour, demonstrating for the first time the benefit of SWATH MS as a technique for HCP analysis. As another alternative, a targeted MS approach can be used to track the clearance of specific known HCP under various process conditions. This study highlights the importance of designing a robust LC-MS/MS workflow that not only allows HCP discovery, but also affords greatly improved process knowledge and capability in HCP removal. As an orthogonal and complementary detection approach to traditional HCP analysis by enzyme-linked immunosorbent assay, the reported LC-MS/MS workflow supports the development of bioprocesses with optimal HCP clearance and the production of safe and high quality therapeutic biopharmaceuticals.
开发了一种基于模块化和自适应质谱(MS)的平台,以提供快速、稳健且灵敏的宿主细胞蛋白(HCP)分析,以支持工艺开发。该平台依靠一维超高效液相色谱(1D UHPLC)结合几种不同的MS数据采集策略,以满足纯化工艺开发的需求。工作流程的设计允许每天对多达20个样品进行HCP组成分析和定量,这种通量对于实时生物工艺开发支持而言至关重要。采用数据依赖型采集(DDA)时,1D UHPLC-MS/MS方法速度极快,并且在检测≥50 ng/mg(ppm)水平的未知HCP时表现出稳健性。将1D UHPLC与所有理论谱图的顺序窗口采集(SWATH)MS相结合,能够在1小时内同时检测和定量单位数ng/mg范围内的所有HCP,首次证明了SWATH MS作为一种HCP分析技术的优势。作为另一种选择,可以使用靶向MS方法来跟踪特定已知HCP在各种工艺条件下的清除情况。本研究强调了设计稳健的LC-MS/MS工作流程的重要性,该流程不仅能实现HCP的发现,还能极大地提升对HCP去除的工艺认知和能力。作为一种与传统酶联免疫吸附测定法进行HCP分析的正交且互补的检测方法,所报道的LC-MS/MS工作流程有助于开发具有最佳HCP清除效果的生物工艺,并生产安全、高质量的治疗性生物药物。